LEARN ABOUT OUR PRESENTERS BELOW AND THEIR DIVERSE BACKGROUNDS!
Dr. Bruce Bonanno
cme cONFERENCE pROGRAM dIRECTOR
SGUSOM graduate 1983, current President of SGUSOM Alumni Association and a member MSNJ (Medical Society of NJ) Opiate Task Force. Recently appointed to the NJ State Trauma System Advisory Committee.
Currently practicing in CentraState Medical Center in Freehold, NJ and is Board Certified in Emergency Medicine. Has been practicing EM for over 30 years in various settings from 12 bed rural hospitals, to a Level One Trauma Center. These hospitals have been in several states including NJ, NY, PA, IA, and SD. Some unusual sites have included an Indian Reservation and a Cruise Ship.
Previously:
Examiner for Board Certification in Emergency Medicine Oral Board.
Chief Medical Consultant for News12NJ and host of a thirty-minute TV medical show.
Spokesperson of the Opiate Task Force of National ACEP and NJ-ACEP,
President of NJ American College of Emergency Physicians (NJ-ACEP), President of National Association of Medical Communicators (NAMC), President of Monmouth-Ocean County Medical Society (MSNJ), and Chairman of National ACEP Public Relations Committee.
Dr. Daniel Herr
cme conference educational director
Daniel L. Herr, MD is the Chief of Surgical Critical care services and Director of the Cardiac Surgery Unit at the University of Maryland. He is responsible for the oversight of the clinical ICU care of cardiac surgery patients, heart transplant, lung transplant, ventricular assist devices and, extracorporeal lung support. Dr Herr serves as an Associate professor of Medicine. Dr Herr’s research interests are in use, of Extra corporeal membrane oxygenation (ECMO) for lung failure, avoidance and treatment of acute confusional states in the ICU and the use of hypothermia for resuscitation. Dr Herr is boarded in the fields of Internal medicine, Critical Care and certified in Neuro-Critical care.
A Fellow of the American College of Critical Care Medicine, Dr. Herr is an experienced principal investigator with special interest in novel therapies and devices. He is proficient in regulatory compliance, protocol design, and pharmacology. His research findings have been published in prominent medical journals such as JAMA, Journal of Neurosurgery, and Critical Care Medicine. He has also authored two book chapters on the subject of nutrition in critical care and endocrine management of the cardiac surgical patient. Most recently he was one of the authors of the Guidelines for Sedation in critically ill patients.
As a recognized expert in the field of critical care, Dr. Herr is frequently invited to speak at medical conferences on topics concerning novel/new treatments and therapies for crucially ill patients. He has served on several Data Safety Monitoring Boards, and often provides consultative services to pharmaceutical companies. Throughout his career, he has been an active member of several medical organizations.
Dr. Herr received a Masters of Science in Pharmacology from Thomas Jefferson University, Philadelphia, PA, and a Medical Degree from St. George’s University School of Medicine, Grenada, W.I. He completed a residency at York Hospital in York, PA, and completed post-graduate training in critical care (medical, surgical and trauma) at Maryland Institute for mergency Medical Services (MIEMSS), University of Maryland Hospital, Baltimore, Maryland, and Memorial Sloan-Kettering, Cornell University, New York, NY.
Prior to assuming his current positions, Dr Herr was Assistant Vice President of Scientific Affairs at MedStar Research Institute, as well as Director of Critical Care Research, and Medical Director of the Surgical Intensive Care Unit at Washington Hospital Center (WHC) in Washington, DC. Dr. Herr was responsible for all critical care research conducted at WHC, and oversaw all MedStar-administered research projects conducted in Baltimore, Maryland. Over the past several years, Dr. Herr served as a key scientific contributor to MedStar’s Office of Research Integrity and served as Chair of the Institutional Review Board (IRB) for eight years. In addition to his clinical and research responsibilities, Dr. Herr was an Associate Professor of Medicine at Georgetown University. Prior to those appointments, Dr. Herr served as Assistant Clinical Professor of Neurosurgery at George Washington University in Washington DC, and was Medical Director of MedSTAR, the renowned trauma transport and emergency program at WHC.
Dr. Charles AdelmaNN
Dr. Charles Adelmann is a gastroenterologist in Norwalk, CT and is affiliated with Norwalk Hospital. He received his medical degree from Chicago Medical School/Rosalind Franklin University of Medicine Science and has been in practice 30 years. He specializes in advanced endoscopic interventional and is experienced in general gastroenterology, biliary tract disease, esophageal disease, pancreatic disease, and gastrointestinal motility disorders.
Dr. Craig Conoscenti
Dr. Conoscenti received BS from Fordham University and his M.D. from St George’s University School of Medicine. He completed his residency and chief residency at Hackensack University Medical Center. Following this he completed his pulmonary critical care medicine fellowship at the Norwalk Hospital/Yale University fellowship program.
He practiced in a clinical academic program at Norwalk Hospital for 18 years serving as a senior consultant in pulmonary and critical care medicine. Additionally, he was research physician in the Hinds Center for Respiratory Research and the director of the diving and hyperbaric medicine division. He was a faculty educator for both the fellowship and residency programs. His specific area of interest clinically and in his research was interstitial lung disease.
Dr. Conoscenti joined Boehringer Ingelheim in 2002 and until 2021 he was the program area lead for the pulmonary fibrosis program and the Medical Expert, Interstitial Lung Disease. He went on to be the Therapeutic Area Head and Executive Director for Interstitial Lung Disease in the Clinical Development and Medical Affairs group. In early November 2023, Dr. Conoscenti took up his current role as Senior Vice President for Clinical Development, Avalyn Pharma, Seattle WA.
He is a Fellow of the American Thoracic Society and the American College of Chest Physicians, where he has held several committee positions, and the European Respiratory Society. He received the Norman S Brady Fellowship where he served sabbatical time at the Brompton Chest Hospital in London studying quantitative and qualitative chest CT analysis.
Dr. daniel culver
Daniel Culver is a pulmonary physician with a long-standing interest in diffuse parenchymal lung diseases, especially sarcoidosis. He has focused on both pulmonary and extrapulmonary disease. A graduate of The Ohio State University, he obtained his medical degree at Heritage College of Osteopathic Mediicne, before completing residency and fellowship at Cleveland Clinic. He is now the Chair of Pulmonary Medicine at Cleveland Clinic. He is the Immediate Past-president of the World Association of Sarcoidosis and Other Granulomatous Disorders, former chair of the FSR Scientific Advisory Board, and a member of the AASOG Executive committee.
Dr. alan davis
Alan practices general and consultative physical medicine and rehabilitation at the University of Utah’s Neilsen Rehabilitation Hospital. He serve this community with wellness activities including an obsession with tea and a passion for joy in the workplace. He has been exploring plant medicine and other psychedelics use to support western medical healing and personal growth. As a psychedelic integration coach with decades of experience in psycho-spiritual healing he has been supporting practitioners stuck, burned out, or in major life transitions find a new direction.
Dr. Peter Dicpinigaitis
Dr. Peter Dicpinigaitis is Professor of Medicine at the Albert Einstein College of Medicine, in New York. He is board-certified in Pulmonary Diseases and Critical Care Medicine. He is a faculty member of the Division of Critical Care Medicine at Montefiore Medical Center and is the founder and director of the Montefiore Cough Center. In addition to experience in all aspects of clinical medicine within the spectrum of pulmonary and critical care, a major focus of Dr. Dicpinigaitis’ clinical research for over 25 years has been in the area of cough. He has authored numerous peer-reviewed journal articles and book chapters on cough, and is considered an authority on the performance of cough challenge studies in clinical research. He served as a co-author on cough management guidelines published by the American College of Chest Physicians as well as the European Respiratory Society, and is the founder and chairman of the biannual American Cough Conference. Dr. Dicpinigaitis also serves as the Editor-in-Chief of the journal LUNG.
Dr. angus friday
Angus is co-founder of Azuros.ai, a new A.I. enabled investment platform for sustainable investments. A graduate of St. George’s University School of Medicine, and holding an MBA from Scotland, Angus founded two medical informatics start-ups in London in the 1990s, and, in one case, sold its intellectual property to Johnson & Johnson. He has taken a keen interest in A.I. in the health space and is actively engaging with academia and practitioners in the UK on this subject.
Angus has 20 years’ experience working locally and internationally on environmental finance, economics and diplomacy. He represented Grenada internationally as its Ambassador to the United Nations, and to the United States, Canada, Mexico and the Organization of American States. He also served in senior roles at the Washington based World Bank. He is a board director for Republic Bank (Grenada), Glenelg Spring Water Inc., and the Island Montessori School. He is an avid diver and sailor and recently re-settled in Grenada while continuing to work internationally.
Dr. sahil gupta
Dr. Sahil Gupta is a highly skilled pain management specialist with a clinical focus on advanced neuromodulation procedures, including spinal cord stimulation, peripheral nerve stimulation, and targeted drug delivery. His expertise extends to managing complex pain conditions with the latest technological advancements in the field. Beyond his clinical practice, Dr. Gupta is actively engaged in clinical research, contributing to the development and refinement of treatments in spinal cord stimulation, targeted drug delivery, and the management of cancer pain. His dedication to both patient care and research underscores his commitment to improving outcomes for those suffering from chronic and acute pain.
Dr. brian houston
Brian Houston is a professor of medicine at the Medical University of South Carolina. As a heart failure cardiologist, his research and clinical interests cover mechanical circulatory support, heart transplant, invasive hemodynamics, right ventricular failure, and the care of inflammatory cardiomyopathies including cardiac sarcoid. Dr. Houston is a renown authority on Chronic Heart failure and end stage heart disease with over 60 articles published including journals such as the New England Journal. He is the medical director of the MUSC mechanical circulatory support program.
Dr. danielle krol
Danielle Krol, MD is a Medical Oncologist with a passion for advancing cancer care and treatment. She is board-certified in Internal Medicine and Medical Oncology, and is a Diplomate of the American Board of Internal Medicine. Dr. Krol is a proud graduate of St. George’s University School of Medicine, and completed an Internal Medicine residency at Drexel University in Philadelphia and a Hematology/Oncology Fellowship at George Washington University in Washington DC. Committed to patient care, Dr. Krol specializes in Breast Cancer and Gynecologic Cancers, with expertise in Cancer Prevention and Risk Reduction. Dr. Krol is passionate about broadening participation in cancer prevention trials and identifying barriers to participation in this space, as well identifying unmet needs regarding risk reduction in high risk individuals especially those with hereditary risk factors. Outside of the clinic, Dr. Krol engages in community outreach and education, aiming to raise awareness about cancer prevention and treatment options.
Dr. amal mattu
Dr. Mattu completed an emergency medicine residency at Thomas Jefferson University Hospital in Philadelphia, after which he completed a teaching fellowship with a special focus on emergency cardiology. Since joining the faculty at the University of Maryland in 1996, he has received more than two dozen teaching awards including national awards from the American Academy of Emergency Medicine, the American College of Emergency Physicians, the Council of Residency Directors in Emergency Medicine, and the Emergency Medicine Residents’ Association; and local honors including the Teacher of the Year for the University of Maryland at Baltimore campus and the Maryland State Emergency Physician of the Year Award. He is a frequent speaker at national and international conferences on topics pertaining to emergency cardiology, emergency care of the elderly, faculty development, and risk management. Dr. Mattu has authored or edited more than 20 textbooks in emergency medicine, and he serves as the Consulting Editor for Emergency Medicine Clinics of North America. Dr. Mattu is currently a tenured Professor, Vice Chair of Academic Affairs, and Director of the Faculty Development Fellowship and Co-Director of the Emergency Cardiology Fellowship for the Department of Emergency Medicine at the University of Maryland School of Medicine.
Dr. jacobo mintzer
Dr. Mintzer is a Professor in the Department of Health Sciences in the College of Health Professions at the Medical University of South Carolina (MUSC) and a staff physician at the Ralph H. Johnson VA Health Care System. He is a Subject Matter Expert for the Ralph H. Johnson VA National Institute for Brain Health as well as a visiting professor at the Hebrew University in Jerusalem, Israel and an honorary professor at the University of Exeter in the UK. He is the former Executive Director of the Roper St. Francis Healthcare System Clinical Biotechnology Research Institute. At MUSC, he developed the Geriatric Psychiatry and Alzheimer’s Research Program in 1991, which includes inpatient, outpatient, and consultation services as well as a fellowship program. Dr. Mintzer has been involved in clinical research on Alzheimer’s disease for the last 20 years and is author of over 230 peer-reviewed research articles. He is the former President of the International Psychogeriatric Association, founding board member of the AARP supported Global Council on Brain Health, board member of the South Carolina Alzheimer’s Association, and former member of the Alzheimer’s Association (national) Public Policy Committee. He is also the former treasurer of the American Association for Geriatric Psychiatry. Dr. Mintzer has devoted most of his career to the understanding and the development of treatments for neuropsychiatric symptoms of dementia.
Dr. luca paoletti
Luca Paoletti MD, MBA is a professor of medicine at the Medical University of South Carolina. He received his undergraduate degree from the University of Virginia and graduated from St. George’s University School of Medicine in 2005. He did his internal medicine training at the University of Connecticut Medical Center, and his pulmonary/critical care fellowship at the Medical University of South Carolina. He serves as the Medical Director of Lung Transplant and the Medical Director of the Adult ECMO program at MUSC. His teaching activities and patient care are focused in the area of pulmonary transplant medicine and does clinical research in advanced lung diseases.
Dr. richard silver
Dr. Richard Silver is a Professor of Medicine and Pediatrics at the Medical University of South Carolina (MUSC). He is a graduate of the University of Tennessee and Vanderbilt University School of Medicine. Dr. Silver completed Internal Medicine residency at the University of North Carolina at Chapel Hill. He trained in Pediatric Rheumatology with Dr. Barbara Ansell at Taplow, Buckinghamshire and at London’s Northwick Park Hospital, followed by a Fellowship in Adult Rheumatology with Dr. Nathan Zvaifler at the University of California, San Diego. In 1981, Dr. Silver was invited by Professor E. Carwile LeRoy to join the faculty at MUSC, where he rose through the ranks and served as Division Director from 1995-2018. In 2007, the MUSC Board of Trustees recognized Dr. Silver as a “Master Teacher” and bestowed the University’s highest academic recognition, “Distinguished University Professor”. The Scleroderma Foundation honored Dr. Silver in 2007 by naming him “Doctor of the Year”. Dr. Silver’s research interest is focused on the pathogenesis and treatment of scleroderma lung disease. He has co-authored more than 250 manuscripts and 50 chapters. During his tenure at MUSC, Dr. Silver has trained more than 100 rheumatology fellows, now practicing throughout the U.S. and at multiple academic institutions.
Dr. timothy vece
Dr. Vece is a pediatric pulmonologist with research interests in rare lung disease and genetic immune deficiencies with pulmonary involvement. He has served as the clinical expert on many translational research teams, including research for familial pulmonary hemorrhage and investigations of the microbiome of the lungs and upper GI tract. Currently, he is focusing on immune-based lung diseases in children and the immune system effects of Childhood interstitial lung disease (chILD) and primary ciliary dyskinesia (PCD). He is conducting clinical and descriptive research on rare lung disorders and is a member of the children’s diffuse and interstitial lung disease research network. His ongoing work focuses on understanding the underlying causes of chILD and PCD, which is key to the development of new management and therapeutic strategies.